Domain/Rusnano starts, unmusically, with $40m investment in CoDa
This article was originally published in Scrip
Executive Summary
As part of their strategic investment partnership, Domain Associates and RusnanoMedInvest (a subsidiary of Rusnano) have made their first joint investment of nearly $40 million into San Diego, California-based CoDa Therapeutics. The funds will be used by CoDa to "pursue late-stage clinical trials".